Boston Scientific
ACURATE IDE Deep Dive Symposium
Dr. Michael Reardon (Houston Methodist DeBakey Heart & Vascular Center and co-principal investigator of the ACURATE IDE trial), Dr. Michael Rinaldi (Sanger Heart & Vascular Institute), Prof Ole De Backer (Rigshospitalet, Copenhagen University Hospital), and Dr. Janar Sathananthan (Chief Medical Officer, Interventional Cardiology Therapies, Boston Scientific) take a closer look at the ACURATE IDE study results presented at TCT 2024.
Learn more as they dive into the key outcomes of the ACURATE IDE study and review the post-hoc analysis in detail.
Learn more as they dive into the key outcomes of the ACURATE IDE study and review the post-hoc analysis in detail.
Comments 0
Login to view comments.
Click here to Login
